Big Gain For Acorda Therapeutics, Inc.
Wed, Dec 02, 2020 at 05:32 PM
Acorda Therapeutics, Inc. (ACOR:NASDAQ) shot up at $0.82, representing a gain of 26.7%. On Tue 01 Dec 20, ACOR:NASDAQ hit a New 2-Week Low of $0.65. The stock got featured on our News Catalysts scanner on Tue 10 Nov 20 at 08:23 AM in the 'EARNINGS' category. From Tue 17 Nov 20, the stock recorded 11.11% Up Days and 10.00% Green Days
The stock spiked on Tue 20 Oct 20 at $1.64 with a volume of 110M+, and its share price has been moving sideways in recent weeks.
About Acorda Therapeutics, Inc. (ACOR:NASDAQ)
Acorda Therapeutics Inc is a biopharmaceutical company. It is engaged in the identification, development & commercialization of novel therapies for the treatment of neurological disorders.
Top 10 Gainers:
- Merrimack Pharmaceuticals, Inc. (MACK:NASDAQ), 59.07%
- Tredegar Corporation (TG:NYSE), 29.86%
- Kingsway Financial Services Inc. (KFS:NYSE), 28.71%
- Cellectar Biosciences, Inc. (CLRB:NASDAQ), 28.71%
- Catabasis Pharmaceuticals, Inc. (CATB:NASDAQ), 28.22%
- FSTX (FSTX:NASDAQ), 27.63%
- Acorda Therapeutics, Inc. (ACOR:NASDAQ), 26.7%
- Sequential Brands Group, Inc. (SQBG:NASDAQ), 25.16%
- Natuzzi S.p.A. (NTZ:NYSE), 24.59%
- Sundial Growers Inc. (SNDL:NASDAQ), 23.83%